FLGC Flora Growth Corp Quarterly EPS earnings growth

Flora Growth Inc - graphic logo of issuer FLGC

Flora Growth Corp. (FLGC) is scaling medical cannabinoid supplies in the US and Germany, capturing niche pharmaceutical markets. The quarterly EPS growth rate confirms the effectiveness of this model. Low costs associated with Colombian plantations ensure pricing leadership, while strict licensing barriers protect the business from competitors. The current value of 17.60 reflects the balance of the operating profit per share metric.

Flora Growth (FLGC) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 01/29/2026

Flora Growth Inc (FLGC) - metric breakdowns and financial figures

- market value and analyst target forecast:
Price Chart Flora Growth|FLGC - Consensus Target
- market capitalization data:
Market Capitalization Flora Growth Corporation|FLGC - Full Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Flora Growth|FLGC - Company Book Value|Market Value to Book Value Ratio floragrowth.ca|FLGC - Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Flora Growth Corp.|FLGC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Flora Growth Corp.|FLGC - Company Aggregate Debts|Debt to Book Value Flora Growth Corporation|FLGC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Flora Growth|Quick Liquidity floragrowth.ca
- earnings and market multiples details:
FLGC - Final Profit|Expected Profit Flora Growth Corp.|FLGC - Market Cap to Earnings|Projected Price to Earnings Flora Growth Corporation|FLGC - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Flora Growth Corporation|FLGC - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Flora Growth|FLGC - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months floragrowth.ca|FLGC - Earnings per share increase in current year|Earnings growth forecast for next year Flora Growth Corp.
- sales volume and revenue information:
FLGC - Company Sales|Company Projected Revenue Flora Growth|FLGC - Price to Sales|Price-to-Projected Revenue Ratio Flora Growth Corporation
Initial company analysis:Flora Growth, FLGC
Manufactured product of Flora Growth Inc

Quarterly EPS measures net income per share, allowing investors to differentiate real business performance from short-term market volatility through a quarterly EPS chart. Steady growth in this metric confirms that Flora Growth Corp. is capitalizing on its advantages in Europe, where licensing barriers and legalization in Germany are driving customer base expansion and strengthening the company's fundamental resilience.

Who Flora Growth Corp. competes with

Indivior (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharma|CRON (Cronos) - Quarterly EPS earnings growth|Canopy Growth Corp. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months High Tide Inc. (HITI)|Year-over-year earnings per share growth for the last twelve months ACB (auroramj.com)|Year-over-year earnings per share growth for the last twelve months Achieve Life Sciences, Inc. ACHV|skyebioscience.com (SKYE) - Earnings per share growth in annualized terms for the last twelve months|ANEB - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months INCR (InterCure Ltd.)|NTRB: Quarterly EPS earnings growth|Nasus Pharma (NSRX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IGC|MIRA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IMCC|adialpharma.com (ADIL) - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months Artelo Biosciences, Inc. ARTL|Year-over-year earnings per one share growth for the last 12 months ENSC|TTNP - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings, Inc.|INM (InMed Pharma) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Akanda Inc|Year-over-year net earnings per share growth for the last 12 months ENVB|BGXX (Bright Green Corp) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth HPCO